FDA — authorised 28 December 1984
- Application: NDA018770
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: TORNALATE
- Indication: AEROSOL, METERED — INHALATION
- Status: approved
🇺🇸 Tornalate in United States
FDA authorised Tornalate on 28 December 1984
Marketing authorisations
FDA — authorised 19 February 1992
- Application: NDA019548
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: TORNALATE
- Indication: SOLUTION — INHALATION
- Status: approved
FDA
- Status: approved
Tornalate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Tornalate approved in United States?
Yes. FDA authorised it on 28 December 1984; FDA authorised it on 19 February 1992; FDA has authorised it.
Who is the marketing authorisation holder for Tornalate in United States?
SANOFI AVENTIS US holds the US marketing authorisation.